{
    "N/R/U": null,
    "Applicant": "AstraZeneca AB",
    "BLA Number": "125586",
    "Proprietary Name": "Andexxa",
    "Proper Name": "Coagulation Factor Xa (Recombinant), Inactivated-zhzo",
    "BLA Type": "351(a)",
    "Strength": "200MG",
    "Dosage Form": "Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "December 31, 2018",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "27",
    "Submission Type": "Supplement",
    "License Number": "2059",
    "Product Number": "002",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "May 03, 2025"
}